ArticlePloS one2021

Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease.

Victory 'Segun Ezeofor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.